ALEXANDER EGGERMONT, general director of Institut Gustave Roussy since 2010, has had his appointment as head of the institute renewed by the French minister of health for another five years. The institute is one of the largest health centers in Europe dedicated to oncology. The past five years has seen a large investment program at... […]
RICHARD O'REILLY will step down as chair of pediatrics at Memorial Sloan Kettering Cancer Center, after nearly 30 years. He will serve as chair until a successor is found, according to Physician-in-Chief Jose Baselga.
THE CENTER TO ADVANCE PALLIATIVE CARE and National Palliative Care Research Center published a state-by-state report card evaluating access to palliative care.
A STAND UP TO CANCER CANADA DREAM TEAM researching approaches to treating triple-negative breast cancer and other aggressive types of breast cancer has been formed following a $9 million investment from a coalition of funders.
JAN SCHLÜCHTER was named chief commercial officer of Myriad Genetics GmbH, effective Oct. 15.
KIRAN TURAGA was named the Sharon K. Wadina Endowed Professor in Sarcoma Research at the Medical College of Wisconsin.
JAMES WADE was named deputy director for quality and network development at the Inova Dwight and Martha Schar Cancer Institute.
SANTOSH KESARI joined the Providence Saint John's Health Center and its John Wayne Cancer Institute.
THREE INVESTIGATORS were named recipients of the 2015 Paul Marks Prize for Cancer Research by Memorial Sloan Kettering Cancer Center. The award recognizes investigators age 45 or younger for their efforts in advancing cancer research.
LORENZ STUDER, director of the Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Center, was named a fellow by the MacArthur Foundation.
